Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Family with sequence similarity 156, member A pseudogene (FAM156A pseudogene)
- Target
- FAM156A pseudogene
- Molecular classification
- Pseudogene
01
Overview
The Family with sequence similarity 156, member A pseudogene (abbreviated FAM156A pseudogene and designated ENSG00000278319) is a DNA segment that resembles a functional gene but does not encode a protein due to accumulated mutations or disruptions such as frameshifts or premature stop codons[1][7][9]. Pseudogenes are often considered genomic remnants and do not contribute direct protein function; however, in some cases pseudogenes can impact gene regulation by acting as microRNA decoys or sources of regulatory RNAs[5]. There is no evidence that FAM156A pseudogene serves as a therapeutic target, nor is it linked to specific diseases or drugs. If your interest is in druggable protein targets, this entry is not appropriate since it does not encode a functional protein or serve as a molecular target in pharmacology[1][7][9].
- Other names
- FAM156A pseudogeneFamily with sequence similarity 156, member A pseudogeneENSG00000278319
02
Mechanism of action
None. Therapeutic mechanisms typically require functional protein products, which pseudogenes lack.
03
Biological functions
Pseudogenes generally lack direct biological functions as functional proteins. However, some pseudogenes are known to regulate their parent genes by producing regulatory RNAs (e.g., microRNA decoys, siRNAs) or through epigenetic mechanisms[5]. There is no evidence for specific functional activity for FAM156A pseudogene; if present, it would be regulatory in nature rather than coding.
04
Disease associations
Pseudogenes as a class can sometimes play indirect roles in disease, such as in cancer or gene regulation[5]. There is no evidence for the FAM156A pseudogene as a specific disease gene.
05
Safety considerations
None known. Because pseudogenes do not encode active proteins, there are no safety concerns specific to FAM156A pseudogene for therapeutic intervention.
06
Interacting drugs
None. Pseudogenes are not targeted by drugs.
07
Biomarkers
None known. Some pseudogenes serve as biomarkers in specific contexts, but there is no evidence for FAM156A pseudogene as a biomarker.
Beyond the preview
Go deeper on Family with sequence similarity 156, member A pseudogene (FAM156A pseudogene).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Family with sequence similarity 156, member A pseudogene (FAM156A pseudogene).